Physicians’ Practice Toward and Knowledge about Proton Pump Inhibitor Prescription in Jeddah, Saudi Arabia

  title={Physicians’ Practice Toward and Knowledge about Proton Pump Inhibitor Prescription in Jeddah, Saudi Arabia},
  author={Rawaa K Alnabulsi and Roaa O Jambi and Nawaf Dhabab and Turky Alsubahi and Mohammed A. Basheikh and Fatemah O Kamel and Rania M Magadmi},
  journal={The International Annals of Medicine},
  • Rawaa K Alnabulsi, Roaa O Jambi, +4 authors Rania M Magadmi
  • Published 2018
  • Medicine
  • The International Annals of Medicine
  • Proton pump inhibitors (PPI) are acid-suppressive agents widely prescribed to patients with common gastrointestinal symptoms. The common belief that PPI have a safe profile and high efficacy level leads to PPI over-prescription. However, the physicians’ knowledge about PPI could also contribute in this over-prescription. Thus, this study aimed to evaluate physicians’ practice towards and knowledge about PPI prescription in Jeddah, Saudi Arabia. A cross-sectional, questionnaire-based survey was… CONTINUE READING


    Attitude and Knowledge of Indian Emergency Care Residents towards Use of Proton Pump Inhibitors
    • 5
    • Highly Influential
    • PDF
    Proton pump inhibitors: perspectives of patients and their GPs.
    • 51
    • PDF
    Use of proton pump inhibitors in general practice
    • C. Tosetti, I. Nanni
    • Medicine
    • World journal of gastrointestinal pharmacology and therapeutics
    • 2017
    • 9
    Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study
    • 34
    • Highly Influential
    Why Do Physicians Prescribe Stress Ulcer Prophylaxis to General Medicine Patients?
    • 30
    • PDF
    Appropriateness of treatment recommendations for PPI in hospital discharge letters
    • 74
    • PDF
    Inappropriate prescribing of proton pump inhibitors in primary care
    • 177
    Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.
    • 90
    Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme.
    • 17